# ADMELOG
> **BLA209196** · Biologics License Application · Sponsor: SANOFI-AVENTIS US · Approved 2017-12-11
## Drug
- **FDA Application Number:** BLA209196
- **Application type:** Biologics License Application
- **Brand name:** ADMELOG
- **Generic name:** INSULIN LISPRO
- **Active ingredients:** INSULIN LISPRO
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** SANOFI-AVENTIS US
- **Manufacturer:** Sanofi-Aventis U.S. LLC
- **First approval:** 2017-12-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209196)
---
*MORVS · CC0 1.0*